Informationen:
Fehler:
ID
23231
Beschreibung
LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00412997
Link
https://clinicaltrials.gov/show/NCT00412997
Stichworte
Versionen (1)
- 29.06.17 29.06.17 -
Hochgeladen am
29. Juni 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Tumors NCT00412997
Eligibility Tumors NCT00412997
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Tumors NCT00412997
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Standard therapy Solid tumour Advanced | Disease Progression | Standard therapy Lacking | Standard therapy Cutaneous T-Cell Lymphoma | Disease Progression | Standard therapy Lacking
Item
patients with either a) histologically-confirmed, advanced solid tumors whose disease has progressed despite standard therapy or for whom no standard therapy exists, or b) cytopathologically confirmed cutaneous t-cell lymphoma (ctcl) whose disease has progressed despite standard therapy or for whom no standard therapy exists. inclusion is irrespective of stage of disease or extent of prior therapy.
boolean
C2936643 (UMLS CUI [1,1])
C0280100 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
C2936643 (UMLS CUI [3,1])
C0332268 (UMLS CUI [3,2])
C2936643 (UMLS CUI [4,1])
C0079773 (UMLS CUI [4,2])
C0242656 (UMLS CUI [5])
C2936643 (UMLS CUI [6,1])
C0332268 (UMLS CUI [6,2])
C0280100 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
C2936643 (UMLS CUI [3,1])
C0332268 (UMLS CUI [3,2])
C2936643 (UMLS CUI [4,1])
C0079773 (UMLS CUI [4,2])
C0242656 (UMLS CUI [5])
C2936643 (UMLS CUI [6,1])
C0332268 (UMLS CUI [6,2])
WHO performance status scale
Item
world health organization (who) performance status of ≤ 2
boolean
C1298650 (UMLS CUI [1])
Laboratory Results
Item
patients must have the adequate laboratory values
boolean
C1254595 (UMLS CUI [1])
Central Nervous System Neoplasms, Primary
Item
patients with a history of primary cns tumors
boolean
C0751620 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
patients with any history of brain metastases
boolean
C0220650 (UMLS CUI [1])
Peripheral Neuropathy CTCAE Grades
Item
patients with any peripheral neuropathy ≥ ctcae grade 2
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,2])
Diarrhea Unresolved CTCAE Grades
Item
patients with unresolved diarrhea ≥ ctcae grade 2
boolean
C0011991 (UMLS CUI [1,1])
C0443342 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
C0443342 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Decreased cardiac function
Item
impairment of cardiac function
boolean
C0232166 (UMLS CUI [1])
Gastrointestinal function Impairment | Gastrointestinal Diseases
Item
impairment of gastrointestinal (gi) function or gi disease
boolean
C0516983 (UMLS CUI [1,1])
C0221099 (UMLS CUI [1,2])
C0017178 (UMLS CUI [2])
C0221099 (UMLS CUI [1,2])
C0017178 (UMLS CUI [2])
Liver diseases | Kidney Diseases
Item
liver or renal disease
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0022658 (UMLS CUI [2])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])